Bruce Pollock: Clinical Trials

1 trial sponsored by Bruce Pollock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Bruce Pollock: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Serotonergic Pharmacotherapy for Agitation of Dementia
Citalopram [Celexa], Perphenazine [Trilafon] - Dementia, Alzheimer Disease
Phase 3CompletedBruce Pollock1995-09-012017-06-16

Conditions studied

Alzheimer Disease (1)  ·  Dementia (1)  ·  Dementia, Vascular (1)  ·  Problem Behavior (1)  ·  Psychomotor Agitation (1)

Interventions

Citalopram (1)  ·  Perphenazine (1)

Countries

United States (1)

Top investigators

Bruce G. Pollock, M.D., Ph.D. (1)

NIH funding

R01MH059666 (1)